Avoro Capital Advisors LLC Argenx Se Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Argenx Se stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 1,238,467 shares of ARGX stock, worth $533 Million. This represents 5.88% of its overall portfolio holdings.
Number of Shares
1,238,467
Previous 1,234,567
0.32%
Holding current value
$533 Million
Previous $470 Million
3.82%
% of portfolio
5.88%
Previous 6.69%
Shares
21 transactions
Others Institutions Holding ARGX
# of Institutions
356Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.37 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.37 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$953 Million0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.12MShares$910 Million0.51% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$802 Million0.13% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $23.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...